<VariationArchive VariationID="1684041" VariationName="NM_002890.3(RASA1):c.1995_1999del (p.Ser665fs)" VariationType="Deletion" Accession="VCV001684041" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2022-05-21" MostRecentSubmission="2022-05-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1675972" VariationID="1684041">
      <GeneList>
        <Gene Symbol="CCNH" FullName="cyclin H" GeneID="902" HGNC_ID="HGNC:1594" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>5q14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="87311471" stop="87412930" display_start="87311471" display_stop="87412930" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="86690078" stop="86708849" display_start="86690078" display_stop="86708849" Strand="-" />
          </Location>
          <OMIM>601953</OMIM>
        </Gene>
        <Gene Symbol="RASA1" FullName="RAS p21 protein activator 1" GeneID="5921" HGNC_ID="HGNC:9871" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>5q14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="87267883" stop="87391916" display_start="87267883" display_stop="87391916" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="86564069" stop="86687742" display_start="86564069" display_stop="86687742" Strand="+" />
          </Location>
          <OMIM>139150</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RASA1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RASA1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_002890.3(RASA1):c.1995_1999del (p.Ser665fs)</Name>
      <CanonicalSPDI>NC_000005.10:87374895:AAAGCAAAG:AAAG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q14.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="87374896" stop="87374900" display_start="87374896" display_stop="87374900" variantLength="5" positionVCF="87374895" referenceAlleleVCF="AAAAGC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="86670713" stop="86670717" display_start="86670713" display_stop="86670717" variantLength="5" positionVCF="86670712" referenceAlleleVCF="AAAAGC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>S488fs</ProteinChange>
      <ProteinChange>S665fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002890.3" sequenceAccession="NM_002890" sequenceVersion="3" change="c.1995_1999delCAAAG" MANESelect="true">
            <Expression>NM_002890.3:c.1995_1999delCAAAG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.87374900_87374904del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.87374900_87374904del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.86670717_86670721del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.86670717_86670721del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011650.1" sequenceAccession="NG_011650" sequenceVersion="1" change="g.111567_111571del">
            <Expression>NG_011650.1:g.111567_111571del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002890.3" sequenceAccession="NM_002890" sequenceVersion="3" change="c.1995_1999del" MANESelect="true">
            <Expression>NM_002890.3:c.1995_1999del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002881.1" sequenceAccession="NP_002881" sequenceVersion="1" change="p.Ser665fs">
            <Expression>NP_002881.1:p.Ser665fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022650.3" sequenceAccession="NM_022650" sequenceVersion="3" change="c.1464_1468del">
            <Expression>NM_022650.3:c.1464_1468del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_072179.1" sequenceAccession="NP_072179" sequenceVersion="1" change="p.Ser488fs">
            <Expression>NP_072179.1:p.Ser488fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001364075.2" sequenceAccession="NM_001364075" sequenceVersion="2" change="c.933+20144_933+20148del">
            <Expression>NM_001364075.2:c.933+20144_933+20148del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2112487030" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002890.3(RASA1):c.1995_1999del (p.Ser665fs) AND Capillary malformation-arteriovenous malformation 1" Accession="RCV002244561" Version="10">
        <ClassifiedConditionList TraitSetID="5197">
          <ClassifiedCondition DB="MedGen" ID="C4747394">Capillary malformation-arteriovenous malformation 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-05-21" MostRecentSubmission="2022-05-21">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="5197" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="652" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Capillary malformation-arteriovenous malformation 1</ElementValue>
                <XRef ID="MONDO:0020783" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMAVM1</ElementValue>
                <XRef Type="MIM" ID="608354" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CMAVM</ElementValue>
                <XRef Type="MIM" ID="608354" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is characterized by the presence of multiple small (1-2 cm in diameter) capillary malformations mostly localized on the face and limbs. Some affected individuals also have associated arteriovenous malformations (AVMs) and/or arteriovenous fistulas (AFVs), fast-flow vascular anomalies that typically arise in the skin, muscle, bone, spine, and brain; life-threatening complications of these lesions can include bleeding, congestive heart failure, and/or neurologic consequences. Symptoms from intracranial AVMs/AVFs appear to occur early in life. Several individuals have Parkes Weber syndrome (multiple micro-AVFs associated with a cutaneous capillary stain and excessive soft-tissue and skeletal growth of an affected limb).</Attribute>
                <XRef ID="NBK52764" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9787" />
                <XRef ID="9787" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21348050</ID>
                <ID Source="BookShelf">NBK52764</ID>
              </Citation>
              <XRef ID="137667" DB="Orphanet" />
              <XRef ID="90307" DB="Orphanet" />
              <XRef ID="C4747394" DB="MedGen" />
              <XRef ID="MONDO:0020783" DB="MONDO" />
              <XRef Type="MIM" ID="608354" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4925229" SubmissionDate="2022-05-17" DateLastUpdated="2022-05-21" DateCreated="2022-05-21">
        <ClinVarSubmissionID localKey="SUB11489031" submittedAssembly="GRCh37" title="SUB11489031" />
        <ClinVarAccession Accession="SCV002513434" DateUpdated="2022-05-21" DateCreated="2022-05-21" Type="SCV" Version="1" SubmitterName="Laboratorio de Genética Hospitales Universitarios Virgen de las Nieves y Clínico San Cecilio (Granada, Spain), Hospitales Universitarios Virgen de las Nieves y Clínico San Cecilio (Granada, Spain)" OrgID="507275" OrganizationCategory="laboratory" OrgAbbreviation="Genetica" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The variant c.1995_1999delCAAAG p.Ser665Argfs*3 detected in the RASA1 gene is a 5 nucleotide deletion that causes a frameshift at position 665 of the protein. Causes a frameshift-type change at position 665 of the protein. This change predicts a substitution of an amino acid amino acid Serine for Arginine and due to the change in the reading pattern it will result in a premature stop codon 3 amino acids later. The protein will have 667 residues, being the native protein 1047. It is not described in clinical databases or in the scientific literature consulted as of the date of this report. It is not annotated in the dbSNP database or in the gnomAD population frequency database.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RASA1">
              <Name>RAS p21 protein activator 1</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_002890.3:exon 15</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002890.3:c.1995_1999delCAAAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608354" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11489031</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4925229" TraitType="Disease" MappingType="XRef" MappingValue="608354" MappingRef="OMIM">
        <MedGen CUI="C4747394" Name="Capillary malformation-arteriovenous malformation 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

